1887

Abstract

Antibiotic resistance in is a major concern worldwide. However, it is unclear whether resistance is associated with only a few highly prevalent clones or numerous and diverse clones. We monitored 349 healthy children and obtained nasopharyngeal cultures at five time points coinciding with health check-ups (4, 7, 10, 18 and 36 months) between 2008 and 2012. A total of 497 isolates from 257 healthy children were characterized using capsular serotyping, multilocus sequence typing and antibiotic resistance genotyping (, and mutations). Among these isolates, 25 serotypes and 66 sequence types (STs) were found, including 24 new STs with 11 new alleles. Although resistance was present in a variety of ST clones, most of the clones (57/66, 86.4 %) had one specific resistant or susceptible genotype. Of 233 phenotypically penicillin-non-susceptible isolates, 196 (84.1 %) belonged to only six clones, comprising ST90, ST236, ST242, ST3787, ST1437 and ST338 and their variants. We concluded that drug-resistant is associated with a limited number of highly prevalent clones that are capable of adapting to the community setting. Furthermore, we analysed the capsular gene evolution in serogroup 6. The strain ST2924 was probably the result of recombination of a 3563 bp fragment of the capsule locus acquired by an ST2924 strain from an ST90 or ST2924 strain. Compared with previous studies, our results showed a different recombination site ( and ) and a different profile (8-7-11), indicating that serogroup 6 strains have multiple sites for recombination as a mechanism of vaccine escape.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.066316-0
2013-12-01
2024-04-26
Loading full text...

Full text loading...

/deliver/fulltext/jmm/62/12/1868.html?itemId=/content/journal/jmm/10.1099/jmm.0.066316-0&mimeType=html&fmt=ahah

References

  1. AlonsoDeVelasco E., Verheul A. F., Verhoef J., Snippe H. 1995; Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol Rev 59:591–603[PubMed]
    [Google Scholar]
  2. Ardanuy C., Rolo D., Fenoll A., Tarrago D., Calatayud L., Liñares J. 2009; Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J Antimicrob Chemother 64:507–510 [View Article][PubMed]
    [Google Scholar]
  3. Bratcher P. E., Kim K. H., Kang J. H., Hong J. Y., Nahm M. H. 2010; Identification of natural pneumococcal isolates expressing serotype 6D by genetic, biochemical and serological characterization. Microbiology 156:555–560 [View Article][PubMed]
    [Google Scholar]
  4. Bratcher P. E., Park I. H., Oliver M. B., Hortal M., Camilli R., Hollingshead S. K., Camou T., Nahm M. H. 2011; Evolution of the capsular gene locus of Streptococcus pneumoniae serogroup 6. Microbiology 157:189–198 [View Article][PubMed]
    [Google Scholar]
  5. Carvalho M. G., Pimenta F. C., Gertz R. E. Jr, Joshi H. H., Trujillo A. A., Keys L. E., Findley J., Moura I. S., Park I. H. other authors 2009; PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007. J Clin Microbiol 47:554–559 [View Article][PubMed]
    [Google Scholar]
  6. Chang B., Otsuka T., Iwaya A., Okazaki M., Matsunaga S., Wada A. 2010; Isolation of Streptococcus pneumoniae serotypes 6C and 6D from the nasopharyngeal mucosa of healthy Japanese children. Jpn J Infect Dis 63:381–383[PubMed]
    [Google Scholar]
  7. Dhingra R. K., Williams R. C. Jr, Reed W. P. 1977; Effects of pneumococcal mucopeptide and capsular polysaccharide on phagocytosis. Infect Immun 15:169–174[PubMed]
    [Google Scholar]
  8. Enright M. C., Spratt B. G. 1998; A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144:3049–3060 [View Article][PubMed]
    [Google Scholar]
  9. Gertz R. E. Jr, Li Z., Pimenta F. C., Jackson D., Juni B. A., Lynfield R., Jorgensen J. H., Carvalho M. G., Beall B. W.Active Bacterial Core Surveillance Team 2010; Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era. J Infect Dis 201:770–775 [View Article][PubMed]
    [Google Scholar]
  10. Jin P., Kong F., Xiao M., Oftadeh S., Zhou F., Liu C., Russell F., Gilbert G. L. 2009; First report of putative Streptococcus pneumoniae serotype 6D among nasopharyngeal isolates from Fijian children. J Infect Dis 200:1375–1380 [View Article][PubMed]
    [Google Scholar]
  11. Kaplan S. L., Barson W. J., Lin P. L., Stovall S. H., Bradley J. S., Tan T. Q., Hoffman J. A., Givner L. B., Mason E. O. Jr 2010; Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children. Pediatrics 125:429–436 [View Article][PubMed]
    [Google Scholar]
  12. Lambertsen L., Brendstrup M., Friis H., Christensen J. J. 2010; Molecular characterization of invasive penicillin non-susceptible Streptococcus pneumoniae from Denmark, 2001 to 2005. Scand J Infect Dis 42:333–340 [View Article][PubMed]
    [Google Scholar]
  13. Magee A. D., Yother J. 2001; Requirement for capsule in colonization by Streptococcus pneumoniae. Infect Immun 69:3755–3761 [View Article][PubMed]
    [Google Scholar]
  14. Mavroidi A., Godoy D., Aanensen D. M., Robinson D. A., Hollingshead S. K., Spratt B. G. 2004; Evolutionary genetics of the capsular locus of serogroup 6 pneumococci. J Bacteriol 186:8181–8192 [View Article][PubMed]
    [Google Scholar]
  15. McEllistrem M. C., Nahm M. H. 2012; Novel pneumococcal serotypes 6C and 6D: anomaly or harbinger. Clin Infect Dis 55:1379–1386 [View Article][PubMed]
    [Google Scholar]
  16. Moore M. R., Gertz R. E. Jr, Woodbury R. L., Barkocy-Gallagher G. A., Schaffner W., Lexau C., Gershman K., Reingold A., Farley M. other authors 2008; Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 197:1016–1027 [View Article][PubMed]
    [Google Scholar]
  17. Nagai K., Shibasaki Y., Hasegawa K., Davies T. A., Jacobs M. R., Ubukata K., Appelbaum P. C. 2001; Evaluation of PCR primers to screen for Streptococcus pneumoniae isolates and β-lactam resistance, and to detect common macrolide resistance determinants. J Antimicrob Chemother 48:915–918 [View Article][PubMed]
    [Google Scholar]
  18. Otsuka T., Chang B., Shirai T., Iwaya A., Wada A., Yamanaka N., Okazaki M.SADO Study Working Group 2013; Individual risk factors associated with nasopharyngeal colonization with Streptococcus pneumoniae and Haemophilus influenzae: a Japanese birth cohort study. Pediatr Infect Dis J 32:709–714 [View Article][PubMed]
    [Google Scholar]
  19. Pillai D. R., Shahinas D., Buzina A., Pollock R. A., Lau R., Khairnar K., Wong A., Farrell D. J., Green K. other authors 2009; Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae. BMC Genomics 10:642 [View Article][PubMed]
    [Google Scholar]
  20. Sadowy E., Izdebski R., Skoczynska A., Grzesiowski P., Gniadkowski M., Hryniewicz W. 2007; Phenotypic and molecular analysis of penicillin-nonsusceptible Streptococcus pneumoniae isolates in Poland. Antimicrob Agents Chemother 51:40–47 [View Article][PubMed]
    [Google Scholar]
  21. Sakai F., Chiba N., Ono A., Yamagata Murayama S., Ubukata K., Sunakawa K., Takahashi T. 2011; Molecular epidemiologic characteristics of Streptococcus pneumoniae isolates from children with meningitis in Japan from 2007 through 2009. J Infect Chemother 17:334–340 [View Article][PubMed]
    [Google Scholar]
  22. Sogstad M. K., Høiby E. A., Caugant D. A. 2006; Molecular characterization of non-penicillin-susceptible Streptococcus pneumoniae in Norway. J Clin Microbiol 44:3225–3230 [View Article][PubMed]
    [Google Scholar]
  23. Song J. H., Baek J. Y., Cheong H. S., Chung D. R., Peck K. R., Ko K. S. 2009; Changes of serotype and genotype in Streptococcus pneumoniae isolates from a Korean hospital in 2007. Diagn Microbiol Infect Dis 63:271–278 [View Article][PubMed]
    [Google Scholar]
  24. Song J. H., Baek J. Y., Ko K. S. 2011; Comparison of capsular genes of Streptococcus pneumoniae serotype 6A, 6B, 6C, and 6D isolates. J Clin Microbiol 49:1758–1764 [View Article][PubMed]
    [Google Scholar]
  25. Sutcliffe J., Grebe T., Tait-Kamradt A., Wondrack L. 1996; Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 40:2562–2566[PubMed]
    [Google Scholar]
  26. Tait-Kamradt A., Clancy J., Cronan M., Dib-Hajj F., Wondrack L., Yuan W., Sutcliffe J. 1997; mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob Agents Chemother 41:2251–2255[PubMed]
    [Google Scholar]
  27. Tajima T., Sato Y., Toyonaga Y., Hanaki H., Sunakawa K. 2013; Nationwide survey of the development of drug-resistant pathogens in the pediatric field in 2007 and 2010: drug sensitivity of Streptococcus pneumoniae in Japan (second report). J Infect Chemother 19:510–516 [View Article][PubMed]
    [Google Scholar]
  28. Temime L., Boelle P. Y., Opatowski L., Guillemot D. 2008; Impact of capsular switch on invasive pneumococcal disease incidence in a vaccinated population. PLoS ONE 3:e3244 [View Article][PubMed]
    [Google Scholar]
  29. van der Linden M., Winkel N., Küntzel S., Farkas A., Perniciaro S. R., Reinert R. R., Imöhl M. 2013; Epidemiology of Streptococcus pneumoniae serogroup 6 isolates from IPD in children and adults in Germany. PLoS ONE 8:e60848 [View Article][PubMed]
    [Google Scholar]
  30. van Gils E. J., Veenhoven R. H., Hak E., Rodenburg G. D., Keijzers W. C., Bogaert D., Trzcinski K., Bruin J. P., van Alphen L. other authors 2010; Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains. JAMA 304:1099–1106 [View Article][PubMed]
    [Google Scholar]
  31. World Health Organization 2012; Pneumococcal vaccines – WHO position paper. Wkly Epidemiol Rec 87:129–144
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.066316-0
Loading
/content/journal/jmm/10.1099/jmm.0.066316-0
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error